HIND - Total Utang marang Modal Vyome Therapeutics

This chart illustrating the total debt-to-equity ratio for Vyome Holdings Inc (HIND) shows a value of 0.00. Vyome Holdings Inc (HIND) is currently in the pre-commercial stage, where a lack of sales makes the business dependent on external research funding. Vyome Holdings Inc (HIND) is currently developing a line of immunological agents for skin therapy, which are presently undergoing clinical trials. The organization is creating unique treatment methods for severe dermatological infections to which microorganisms do not develop resistance.

HIND: Total Utang marang Modal Vyome Holdings 16.08.2025 - 01.11.2026

Rincian analitis perusahaan Vyome Holdings Inc

- rega lan prakiraan konsensus rega:
Bagan rega Vyome Holdings|HIND - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Vyome Holdings|HIND - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Vyome Holdings|HIND - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku reshapelifesciences.com|HIND - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Vyome Holdings Inc|HIND - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Vyome Holdings Inc|HIND - Gunggung utang perusahaan|Utang marang nilai buku Vyome Holdings|HIND - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Vyome Holdings|Likuiditas cepet reshapelifesciences.com
- informasi bathi lan kelipatan valuasi:
HIND - Penghasilan resik
Analisis dhasar perusahaan:Vyome Holdings

To stress-test assets, an investor evaluates business dependence on external loans via the total liabilities-to-equity ratio. For Vyome Holdings Inc (HIND), which develops Lap-Band systems and obesity medications, the debt-to-equity ratio dynamics determine the balance between aggressive innovation financing and default risk during market volatility.

Analisis pesaing Vyome Holdings Inc

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA: Rasio Total Utang marang Ekuitas|SVRA: Utang marang Ekuitas|RIGL (Rigel Pharmaceuticals) - Rasio Total Utang marang Ekuitas|Utang marang Modal anaptysbio.com (ANAB)|Utang marang Ekuitas Astria Therapeutics, Inc.|Utang marang Modal enGene Holdings Inc ENGN|Utang marang Ekuitas RAPT Therapeutics, Inc. (RAPT)|Rasio Total Utang marang Ekuitas aerovatetx.com JBIO|Total Utang marang Modal ACRS (Aclaris Therapeutics)|kyvernatx.com (KYTX) - Utang marang Modal|TLSA: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CABA (Cabaletta Bio Inc.)|VTYX: Total Utang marang Modal|Theratechnologies, Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Avalo Therapeutics, Inc|Utang marang Modal eledon.com ELDN|Utang marang Ekuitas Agenus Inc. (AGEN)|Utang marang Ekuitas CLYM (Climb Bio Inc.)|Total Utang marang Modal ZURA (Zura Bio Limited)|ATYR: Rasio Utang marang Ekuitas|Adagene Corp - Total Utang marang Modal|Koefisien Total Utang marang Modal ImageneBio Inc IMA|shattucklabs.com (STTK) - Utang marang Ekuitas|Rasio Utang marang Ekuitas EQ|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|IMUX - Rasio Utang marang Modal|Utang marang Ekuitas Atara Biotherapeutics (ATRA)|Koefisien Total Utang marang Modal inflarx.de|X4 Pharmaceuticals, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACET|Celularity Corp - Total Utang marang Modal|Koefisien Total Utang marang Modal INmune Bio Corporation INMB|Barinthus Biotherapeutics (BRNS) - Utang marang Ekuitas|Rasio Utang marang Ekuitas KZR|SABS (SAB Biotherapeutics, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Akari Therapeutics PLC (AKTX)|Total Utang marang Modal ENLV|QTTB (q32bio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|Koefisien Total Utang marang Modal edesabiotech.com (EDSA)|IBIO - Utang marang Ekuitas|CARM (Carisma Therapeutics) - Rasio Utang marang Ekuitas|XTLB: Total Utang marang Modal|Rasio Utang marang Ekuitas BOLT|Utang marang Ekuitas HCW Biologics, Inc.|Aptevo - Utang Agregat marang Ekuitas|Total Utang marang Modal AIM|ADTX (aditxt.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GRI (GRI Bio Corp)|Total Utang marang Modal XORTX Corp XRTX|REVB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi INDP (indaptusrx.com)|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas CalciMedica|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal Allakos Therapeutics|Rasio Total Utang marang Ekuitas HOOK (HOOKIPA Pharma Inc.)|IGMS (igmbio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Koefisien Total Utang marang Modal Ocean Biomedical Inc (OCEA)|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas